Document Classification

Section Type: METHODS

Text: In this study, we randomized 15 patients to a routine pharmacological treatment (n = 5, age 66 [standard deviation 6] years, FEV (1) 30. 5 [5. 1] % pred, PaO (2) 65 [6] mmHg, PaCO (2) 52. 4 [6. 0] mmHg) or to a routine treatment and NIV (using the Synchrony BiPAP device [Respironics, Inc, Murrsville, PA]) (n = 10, age 65 [7] years, FEV (1) 29. 5 [9. 0] % pred, PaO (2) 59 [13] mmHg, PaCO (2) 55. 4 [7. 7] mmHg) for 6 months.